300238 冠昊生物
按盤價 
17.330 +0.200 (+1.168%)
17.330 +0.200 (+1.168%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.795 | 5.159 | 6.165 | -48.504 | 9.733 |
| 總資產報酬率 ROA (%) | 3.495 | 3.827 | 4.597 | -34.802 | 6.598 |
| 投入資產回報率 ROIC (%) | 3.779 | 4.256 | 5.169 | -39.419 | 7.594 | 邊際利潤分析 |
| 銷售毛利率 (%) | 77.695 | 79.462 | 79.126 | 76.246 | 75.114 |
| 營業利潤率 (%) | 10.713 | 7.482 | 8.409 | -77.406 | 16.679 |
| 息稅前利潤/營業總收入 (%) | 11.869 | 7.784 | 9.263 | -76.086 | 18.174 |
| 淨利潤/營業總收入 (%) | 6.961 | 4.400 | 5.214 | -86.841 | 10.376 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.160 | 151.827 | 136.150 | -5.834 | 81.748 |
| 價值變動淨收益/利潤總額(%) | 0.597 | 2.164 | -11.344 | 3.760 | -5.710 |
| 營業外收支淨額/利潤總額(%) | 2.111 | -0.801 | -5.919 | 0.185 | 0.608 | 償債能力分析 |
| 流動比率 (X) | 1.975 | 1.493 | 1.547 | 1.582 | 1.660 |
| 速動比率 (X) | 1.426 | 1.052 | 1.133 | 1.255 | 1.124 |
| 資產負債率 (%) | 36.283 | 38.018 | 32.764 | 35.706 | 31.907 |
| 帶息債務/全部投入資本 (%) | 17.572 | 16.185 | 7.296 | 10.371 | 9.534 |
| 股東權益/帶息債務 (%) | 447.377 | 488.309 | 1,184.959 | 783.020 | 852.859 |
| 股東權益/負債合計 (%) | 203.592 | 189.102 | 234.149 | 202.793 | 223.610 |
| 利息保障倍數 (X) | 12.831 | 21.541 | 6.999 | -51.983 | 13.049 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 49.457 | 57.549 | 59.284 | 85.248 | 82.110 |
| 存貨周轉天數 (天) | 334.006 | 348.411 | 284.357 | 406.164 | 395.607 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 09/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
